The independent data management committee on the Intracept randomized controlled trial (RCT) has halted the study for efficacy at a prespecified interim analysis. The clinical trial found that for a ...
MARLBOROUGH, Mass., Nov. 17, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only ...
The Intracept Intraosseous Nerve Ablation System is intended to be used in conjunction with radiofrequency (RF) generators for the ablation of basivertebral nerves of the L3 through S1 vertebrae for ...
Nerve ablation uses heat to destroy nerves and decrease chronic pain signals. This procedure often takes 15 minutes to an ...
This morning Boston Scientific Corp. reported plans to acquire privately held Relievant Medsystems Inc. for an upfront cash payment of $850 million plus undisclosed payments contingent on sales ...
Intracept is a cutting edge procedure that involves ablation of the basivertebral nerves for the relief of chronic low back pain that results from the degeneration of the lumbar discs. By targeting a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results